Buprenorphine And Naloxone 62756-0969
Product NDC
62756-0969- Manufacturer
- Sun Pharmaceutical Industries, Inc.
- Dosage Form
- Tablet
- Route
- Sublingual
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- July 18, 2017
- Listing Expires
- December 31, 2027
- Application
- ANDA201633
Active Ingredients
| Ingredient | Strength |
|---|---|
| Buprenorphine Hydrochloride | 2 mg/1 |
| Naloxone Hydrochloride Dihydrate | .5 mg/1 |
Drug Class
Opioid Antagonist [EPC]Opioid Antagonists [MoA]Partial Opioid Agonist [EPC]
Packaging Options(2)
3 BLISTER PACK in 1 CARTON (62756-969-64) / 10 TABLET in 1 BLISTER PACK
30 TABLET in 1 BOTTLE (62756-969-83)